Pilot Study of Neoadjuvant Modified FOLFIRINOX or Gemcitabine-nab Paclitaxel Followed by Stereotactic Body Radiotherapy (SBRT) for Patients With Locally Advanced Pancreatic Cancer and Borderline Pancreatic Inoperable Cancers
Summary
The purpose of this pilot study is to evaluate neoadjuvant therapy followed by stereotactic body radiotherapy (SBRT) for patients with borderline resectable and unresectable pancreas cancers.
General Information
NCT#: NCT03641183
Study ID: IRB00339168
Trial Phase: Pilot
Trial Sponsor: University of Alabama
Therapies Used in This Trial: Nab-paclitaxel, Fluorouracil, Gemcitabine, Oxaliplatin, Stereotactic body radiotherapy (SBRT), Irinotecan, Leucovorin, FOLFIRINOX